Developer docs
API playgroundTry for free, no card

Search company profiles

Oxford Global

Full company profile

uuid000eta5

Namestring
Oxford Global
Legal namestring
Oxford Global Marketing Ltd.
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Oxford Global Marketing Ltd. is a privately held UK-based B2B event services and media company headquartered in Oxford with a regional office in Boston, Massachusetts. Founded in 2007 and operating with 11-50 employees, the company convenes senior leaders, scientific experts, and decision-makers across the global life-sciences ecosystem through three interconnected brand platforms — Discovery & Development, NextGen Biomed, and Precision Medicine — covering the full R&D value chain from early drug discovery through precision medicine and clinical innovation. Its core offerings include large-scale international conferences, monthly curated thought leader webinars, executive interviews, and editorial insights, supported by an event management technology stack that includes a proprietary event app for attendee networking and meeting coordination, and the LifeScienceXchange community platform for ongoing digital engagement.

The company's revenue model combines four streams: conference and event revenue from registration fees and corporate sponsorship, subscription-based recurring monthly thought leader webinars, B2B digital marketing services for life-science organizations, and advertising/sponsored editorial content. Go-to-market is event-driven and enterprise-focused, targeting horizontal life-sciences segments including global pharmaceutical companies, emerging biotechnology firms, academic institutions, investors, and policymakers. Pricing is not publicly disclosed; the company sells sponsorship, partnership, and registration packages to enterprise buyers. Under CEO Cerlin Roberts, the company positions itself as a neutral, independent platform for life-sciences dialogue, with no disclosed external investors, parent company, or funding rounds.

Oxford Global operates in a fragmented B2B specialist media and events market alongside other life-sciences conference organizers, with competitive differentiation rooted in its decadal positioning, multi-stakeholder community access, and cross-vertical brand portfolio rather than proprietary technology. The firm's technology is operational rather than differentiated — focused on event logistics, content distribution, and digital marketing delivery — and it does not develop or market AI, data, or software products. Oxford Global appears to function as a bootstrapped, founder-led niche media business with international reach concentrated primarily in the UK and US.

Short descriptiontext

Oxford Global is a privately held UK-based B2B event services company that convenes senior leaders across the life-sciences ecosystem via international conferences, monthly webinars, editorial content, and the LifeScienceXchange community platform, serving pharma, biotech, academia, investors, and policymakers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOxford, United Kingdom
HQ citystring
Oxford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences conferences, biomedical event management, pharma networking events, precision medicine summits, scientific congress services
NAICS code1 code
  • Professional, Scientific, and Technical Services541
Product category
Life Sciences Event Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Conference and Event Revenue
TypeSubscription Recurring
Description

Revenue generated from large-scale international conferences and events in the life-sciences sector, including registration fees and sponsorship opportunities from pharma, biotech, and academic entities

oxfordglobal.com
2Monthly Thought Leader Webinars
TypeSubscription Recurring
Description

Monthly curated discussions bringing senior voices together, generating revenue through participation fees and sponsorship

oxfordglobal.com
3Digital Marketing Services
TypeProfessional Services
Description

B2B digital marketing services provided to life-science organizations, including sponsorships and partnership opportunities

oxfordglobal.com
4Executive Content and Insights
TypeAdvertising
Description

Trusted editorial insight capturing themes from global convenings, potentially including sponsored content and thought leadership packages

oxfordglobal.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Discovery & Development
Description

Enabling high-potential drug candidates to progress from early discovery to the clinic.

oxfordglobal.com
+2 more records
Core offering1 text field

Oxford Global operates large-scale international conferences, monthly thought leader webinars, and executive editorial content for the life-sciences industry. Through its three brands (Discovery & Development, NextGen Biomed, and Precision Medicine), the company convenes global pharma, emerging biotech, academia, investors, and policymakers to enable networking, knowledge exchange, and R&D collaboration across discovery, development, and clinical innovation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Events surpass attendee expectations through open exchange between persons with true relevant knowledge
+1 more record
Product overview1 text field

Oxford Global operates as a multi-brand platform offering a portfolio of three interconnected brands (Discovery & Development, NextGen Biomed, and Precision Medicine) that serve the life-science community through large-scale international conferences, monthly thought leader webinars, and executive editorial content. The company provides in-person event services and digital marketing services as supporting offerings. Together, these products enable meaningful dialogue across discovery, development, and clinical innovation, connecting pharma, biotech, academia, investors, and policymakers.

Product and service1 record
1Discovery & Development Conferences
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1LifeScienceXchange
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Oxford Global operates the LifeScienceXChange platform as part of its NextGen Biomed brand, providing a community platform for life-science professionals to connect and engage beyond physical events.

oxfordglobal.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeOthers
Description

Drug Discovery World is a B2B media brand for the drug discovery and development community, providing editorial content and conferences that partially overlap with Oxford Global's editorial and event offerings.

TypeBroad incumbent
Description

Reuters Events hosts large industry conferences and virtual summits for pharma, biotech, and healthcare, operating at much greater scale but with comparable audience-targeting and sponsorship models.

TypeDirect peer
Description

Hanson Wade runs large-scale, invitation-only conferences and summits focused on the life-sciences industry, very closely mirroring Oxford Global's model of curated senior-level networking for pharma, biotech, and investors.

TypeDirect peer
Description

World Congress produces industry-leading conferences and summits across pharma, biotech, and healthcare, with similar B2B event monetization tied to sponsorships and registrations in life sciences.

TypeOthers
Description

Industry Dive operates BioPharma Dive, a digital media and events brand covering pharma/biotech; it is a thematic neighbor rather than a direct competitor but targets the same senior decision-makers Oxford Global convenes.

TypeDirect peer
Description

CHI runs major life-sciences conferences (e.g., Molecular Medicine Tri-Conference, PEG Summit) and digital content programs that overlap directly with Oxford Global's Discovery & Development and Precision Medicine brands.

TypeBroad incumbent
Description

Informa runs one of the world's largest events portfolios including major life-sciences brands, making it a scaled incumbent competing for the same pharma/biotech sponsorship dollars.

TypeBroad incumbent
Description

Clarion Events operates a broad B2B events portfolio that includes life-sciences segments; it competes indirectly for life-science sponsorships and event audience share.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Oxford Global

Life Sciences Event Servicesoxfordglobal.co.uk

Oxford Global is a privately held UK-based B2B event services company that convenes senior leaders across the life-sciences ecosystem via international conferences, monthly webinars, editorial content, and the LifeScienceXchange community platform, serving pharma, biotech, academia, investors, and policymakers.

What Oxford Global does

Oxford Global Marketing Ltd. is a privately held UK-based B2B event services and media company headquartered in Oxford with a regional office in Boston, Massachusetts. Founded in 2007 and operating with 11-50 employees, the company convenes senior leaders, scientific experts, and decision-makers across the global life-sciences ecosystem through three interconnected brand platforms — Discovery & Development, NextGen Biomed, and Precision Medicine — covering the full R&D value chain from early drug discovery through precision medicine and clinical innovation. Its core offerings include large-scale international conferences, monthly curated thought leader webinars, executive interviews, and editorial insights, supported by an event management technology stack that includes a proprietary event app for attendee networking and meeting coordination, and the LifeScienceXchange community platform for ongoing digital engagement.

The company's revenue model combines four streams: conference and event revenue from registration fees and corporate sponsorship, subscription-based recurring monthly thought leader webinars, B2B digital marketing services for life-science organizations, and advertising/sponsored editorial content. Go-to-market is event-driven and enterprise-focused, targeting horizontal life-sciences segments including global pharmaceutical companies, emerging biotechnology firms, academic institutions, investors, and policymakers. Pricing is not publicly disclosed; the company sells sponsorship, partnership, and registration packages to enterprise buyers. Under CEO Cerlin Roberts, the company positions itself as a neutral, independent platform for life-sciences dialogue, with no disclosed external investors, parent company, or funding rounds.

Oxford Global operates in a fragmented B2B specialist media and events market alongside other life-sciences conference organizers, with competitive differentiation rooted in its decadal positioning, multi-stakeholder community access, and cross-vertical brand portfolio rather than proprietary technology. The firm's technology is operational rather than differentiated — focused on event logistics, content distribution, and digital marketing delivery — and it does not develop or market AI, data, or software products. Oxford Global appears to function as a bootstrapped, founder-led niche media business with international reach concentrated primarily in the UK and US.

Oxford Global firmographics

Firmographics
Name
Oxford Global
Legal name
Oxford Global Marketing Ltd.
Website
https://oxfordglobal.co.uk
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
Oxford Global is a privately held UK-based B2B event services company that convenes senior leaders across the life-sciences ecosystem via international conferences, monthly webinars, editorial content, and the LifeScienceXchange community platform, serving pharma, biotech, academia, investors, and policymakers.
Ownership category
akta.pro rank

Where Oxford Global is headquartered

Location

Headquarters

HQ city
Oxford
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Oxford Global business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Conference and Event Revenue: Revenue generated from large-scale international conferences and events in the life-sciences sector, including registration fees and sponsorship opportunities from pharma, biotech, and academic entities
  2. Monthly Thought Leader Webinars: Monthly curated discussions bringing senior voices together, generating revenue through participation fees and sponsorship
  3. Digital Marketing Services: B2B digital marketing services provided to life-science organizations, including sponsorships and partnership opportunities
  4. Executive Content and Insights: Trusted editorial insight capturing themes from global convenings, potentially including sponsored content and thought leadership packages

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Oxford Global product offering

Product offering

Core offering

Oxford Global operates large-scale international conferences, monthly thought leader webinars, and executive editorial content for the life-sciences industry. Through its three brands (Discovery & Development, NextGen Biomed, and Precision Medicine), the company convenes global pharma, emerging biotech, academia, investors, and policymakers to enable networking, knowledge exchange, and R&D collaboration across discovery, development, and clinical innovation.

Product overview

Oxford Global operates as a multi-brand platform offering a portfolio of three interconnected brands (Discovery & Development, NextGen Biomed, and Precision Medicine) that serve the life-science community through large-scale international conferences, monthly thought leader webinars, and executive editorial content. The company provides in-person event services and digital marketing services as supporting offerings. Together, these products enable meaningful dialogue across discovery, development, and clinical innovation, connecting pharma, biotech, academia, investors, and policymakers.

Differentiator

Problem solved

Functional benefit

Brands

  • Discovery & Development: Enabling high-potential drug candidates to progress from early discovery to the clinic.
  • NextGen Biomed
  • Precision Medicine

Products and services

  • Discovery & Development Conferences

Quantifiable outcome

  • Events surpass attendee expectations through open exchange between persons with true relevant knowledge
  • +1 more outcomes

Companies that use Oxford Global

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Oxford Global technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Oxford Global partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • LifeScienceXchangecoreStrategic or Co-development PartnerOxford Global operates the LifeScienceXChange platform as part of its NextGen Biomed brand, providing a community platform for life-science professionals to connect and engage beyond physical events.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Oxford Global competitors and assessment

Company assessment

Others

  • Drug Discovery World: Drug Discovery World is a B2B media brand for the drug discovery and development community, providing editorial content and conferences that partially overlap with Oxford Global's editorial and event offerings.
  • BioPharma Dive / Industry Dive: Industry Dive operates BioPharma Dive, a digital media and events brand covering pharma/biotech; it is a thematic neighbor rather than a direct competitor but targets the same senior decision-makers Oxford Global convenes.

Broad incumbents

  • Reuters Events: Reuters Events hosts large industry conferences and virtual summits for pharma, biotech, and healthcare, operating at much greater scale but with comparable audience-targeting and sponsorship models.
  • Informa (Life Sciences Division): Informa runs one of the world's largest events portfolios including major life-sciences brands, making it a scaled incumbent competing for the same pharma/biotech sponsorship dollars.
  • Clarion Events: Clarion Events operates a broad B2B events portfolio that includes life-sciences segments; it competes indirectly for life-science sponsorships and event audience share.

Direct peers

  • Hanson Wade: Hanson Wade runs large-scale, invitation-only conferences and summits focused on the life-sciences industry, very closely mirroring Oxford Global's model of curated senior-level networking for pharma, biotech, and investors.
  • World Congress: World Congress produces industry-leading conferences and summits across pharma, biotech, and healthcare, with similar B2B event monetization tied to sponsorships and registrations in life sciences.
  • Cambridge Healthtech Institute (CHI): CHI runs major life-sciences conferences (e.g., Molecular Medicine Tri-Conference, PEG Summit) and digital content programs that overlap directly with Oxford Global's Discovery & Development and Precision Medicine brands.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Oxford Global social profiles

Digital presence

Oxford Global financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Oxford Global leadership team

Management profile

Number of profiles

Profiles1 record

Oxford Global funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Oxford Global M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oxford Global

What does Oxford Global do?

Oxford Global operates large-scale international conferences, monthly thought leader webinars, and executive editorial content for the life-sciences industry. Through its three brands (Discovery & Development, NextGen Biomed, and Precision Medicine), the company convenes global pharma, emerging biotech, academia, investors, and policymakers to enable networking, knowledge exchange, and R&D collaboration across discovery, development, and clinical innovation.

Is Oxford Global a public or private company?

Oxford Global is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Oxford Global founded?

Oxford Global was founded in 2007. It employs 11 to 50 people.

Where is Oxford Global based?

Oxford Global is headquartered in Oxford, United Kingdom, in the Europe region.

How does Oxford Global make money?

Four revenue lines are on record. Conference and Event Revenue is the primary driver. The others are monthly Thought Leader Webinars, digital Marketing Services and executive Content and Insights.

Who are Oxford Global's main competitors?

Others on record are Drug Discovery World and BioPharma Dive / Industry Dive. Broad incumbents are Reuters Events, Informa (Life Sciences Division) and Clarion Events. Direct peers are Hanson Wade, World Congress and Cambridge Healthtech Institute (CHI).

Does Oxford Global have an API?

No public API is recorded for Oxford Global.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireErnexa Therapeutics to Present at Oxford Global’s Cell 2025Ernexa Therapeutics announced it will present at Oxford Global's Cell 2025 conference in London on November 12, 2025, with President and CEO Sanjeev Luther delivering two presentations on preparing cell therapies for clinical translation and participating in a panel on development challenges. The presentations will focus on Ernexa's engineered induced mesenchymal stem cell (iMSC) platform and strategies for advancing off-the-shelf allogeneic cell therapies from development to clinical application. Cell 2025 is Oxford Global's flagship event for bioprocessing and advanced therapy professionals, bringing together leaders from pharma, biotech, academia, and regulatory institutions.OxfordglobalNextGen Omics, Tech & Data 2026Oxford Global is organizing the NextGen Omics, Tech & Data 2026 conference in London to facilitate discussions on multi-omics and spatial biology among pharmaceutical and biotech experts. The event features dedicated programs for young scientist awards, keynote addresses from industry leaders, and strategic sessions aimed at fostering pharma-academic partnerships and technology adoption.OxfordglobalUnlocking Insights: The Challenges and Future of Multi-Omics Data IntegrationA panel discussion at Oxford Global's PharmaData 2022 event examined challenges and opportunities in multi-omics data integration and visualisation, moderated by GSK's Fausto Artico with Boehringer Ingelheim's Hanati Tuoken and the Sylvester Comprehensive Cancer Center's Vasileios Stathias. Speakers cited data quality, infrastructure choice, and the need for explainable AI, with Tuoken arguing academic success will drive pharma adoption.